Metabolism and Target Organ Damage

Milestone Achieved: Metabolism and Target Organ Damage Publishes Over 100 Articles

We extend our heartfelt thanks to our Editor-in-Chief, Prof. Amedeo Lonardo, as well as to every author, reviewer, and Editorial Board member for their invaluable contributions.

Call for Papers: Metabolic and Alcohol-Related Dual Liver Injury: Exploring MetALD

This Special Issue aims to explore the dual impact of these factors on liver health, specifically focusing on Metabolic Dysfunction and Alcohol-associated Liver Disease (MetALD).

Call for Papers: Metabolic Mysteries – The Role of Copper Dysregulation in Liver Disease

Guest Editors Prof. Ralf Weiskirchen and Prof. Wolfgang Stremmel have been named among the world’s top 2% of scientists for 2024!

A Special Interview with Prof. Matias A Avila, Newly Appointed Editorial Board Member of Metabolism and Target Organ Damage

Dr. Matias A Avila is a Professor of Biochemistry and Molecular Biology at the University of Navarra and Co-Director of the Solid Tumors Program at Cima.

Congratulations! Twenty-eight Editorial Board Members of Metabolism and Target Organ Damage Named among World’s Top 2% of Scientists for 2024!

This prestigious ranking identifies the top 2% of scientists globally from over 7 million scientists, spanning 22 fields and 174 sub-disciplines.

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Sarcopenia in the setting of nonalcoholic fatty liver

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Articles

Most Recent | Most Viewed | Most Downloaded

Fatty liver disease in the pediatric population: history, definitions, and challenges in nomenclature (NAFLD/MAFLD/MASLD)

Raúl Gómez-Mendoza, ... Norberto Chávez-Tapia

Open Access Perspective DOI: 10.20517/mtod.2024.108 28 Apr 2025

Views: Downloads:

Download PDF

Shared genetic architecture between metabolic dysfunction-associated steatotic liver disease and cardiometabolic traits comorbidities: a genome-wide pleiotropic and multi-omics study

Xuan-Yu Wang

, ... Ying-Yu Xie

Open Access Original Article DOI: 10.20517/mtod.2024.129 20 Apr 2025

Views: Downloads:

Download PDF

Impact of obstructive sleep apnea on postoperative outcomes after SADI-S: a retrospective MBSAQIP database analysis with literature review on behalf of TROGSS - The Robotic Global Surgical Society

Samantha Redden Chirinos, ... Rodolfo J. Oviedo

Open Access Original Article DOI: 10.20517/mtod.2024.91 16 Apr 2025

Views: Downloads:

Download PDF

Prognostic performance of the neutrophil-lymphocyte ratio for early complications following sleeve gastrectomy

Luz F. Huertas-Campos, ... Carlos J. Toro-Huamanchumo

Open Access Original Article DOI: 10.20517/mtod.2024.109 9 Apr 2025

Views: Downloads:

Download PDF

MASLD or MAFLD: fatty liver by any name will pose the same challenge

Anil Chandra Anand, ...Dibyalochan Praharaj,

Open Access Editorial DOI: 10.20517/mtod.2025.18 1 Apr 2025

Views: Downloads:

Download PDF

Most Cited Papers In Last Two Years

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Stefano Ballestri

, ... Amedeo Lonardo

Open Access Review DOI: 10.20517/mtod.2022.23 30 Jan 2023

Views: Downloads:

Download PDF

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Christopher D. Byrne

, Giovanni Targher

Open Access Perspective DOI: 10.20517/mtod.2024.06 26 Feb 2024

Views: Downloads:

Download PDF

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Simonetta Lugari, ... Amedeo Lonardo

Open Access Review DOI: 10.20517/mtod.2022.38 30 Mar 2023

Views: Downloads:

Download PDF

Webinars

Ongoing Special Issues

The AI Revolution in Metabolic Surgery: A New Era Begins

Prof. Dr. Rodolfo J. Oviedo; Dr. Adel Karim Abou-Mrad

Submission Deadline: 15 Oct 2025

Published articles: 0

Metabolic Syndrome, Obesity, and Hypertension: A Deep Dive

Dr. Yang Wang; Dr. Zhixing Fan; Dr. Xintian Cai

Submission Deadline: 15 Oct 2025

Published articles: 0

Editorial Board

Partners

Data

727

Authors

H-index

127

Articles

On Board Editors

2021

Published Since

For Authors

For Reviewers

Peer Review Guidelines

For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Topics Collection

Topic: Organ Dysfunction in Metabolic-Associated Fatty Liver Disease: Effect of Cofactors

Topic: Sex Differences in Dysmetabolic Organ Damage and Senescence

Topic: Metabolic and Bariatric Surgery: Current Situation and Future Challenges

Latest Issue

All Issues

Volume 5, Issue 2 (in progress)

M&TOD 2024 Best Paper Award Announced

Top 5 Most-Read Articles in Metabolism and Target Organ Damage for 2024

Milestone Achieved: Metabolism and Target Organ Damage Publishes Over 100 Articles

We extend our heartfelt thanks to our Editor-in-Chief, Prof. Amedeo Lonardo, as well as to every author, reviewer, and Editorial Board member for their invaluable contributions.

Call for Papers: Metabolic and Alcohol-Related Dual Liver Injury: Exploring MetALD

This Special Issue aims to explore the dual impact of these factors on liver health, specifically focusing on Metabolic Dysfunction and Alcohol-associated Liver Disease (MetALD).

Call for Papers: Metabolic Mysteries – The Role of Copper Dysregulation in Liver Disease

Guest Editors Prof. Ralf Weiskirchen and Prof. Wolfgang Stremmel have been named among the world’s top 2% of scientists for 2024!

A Special Interview with Prof. Matias A Avila, Newly Appointed Editorial Board Member of Metabolism and Target Organ Damage

Dr. Matias A Avila is a Professor of Biochemistry and Molecular Biology at the University of Navarra and Co-Director of the Solid Tumors Program at Cima.

Congratulations! Twenty-eight Editorial Board Members of Metabolism and Target Organ Damage Named among World’s Top 2% of Scientists for 2024!

This prestigious ranking identifies the top 2% of scientists globally from over 7 million scientists, spanning 22 fields and 174 sub-disciplines.

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Published articles: 0

Metabolic Syndrome, Obesity, and Hypertension: A Deep Dive

Dr. Yang Wang; Dr. Zhixing Fan; Dr. Xintian Cai

Submission Deadline: 15 Oct 2025

Published articles: 0

News

Metabolism and Target Organ Damage

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Sarcopenia in the setting of nonalcoholic fatty liver

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Articles

Fatty liver disease in the pediatric population: history, definitions, and challenges in nomenclature (NAFLD/MAFLD/MASLD)

Shared genetic architecture between metabolic dysfunction-associated steatotic liver disease and cardiometabolic traits comorbidities: a genome-wide pleiotropic and multi-omics study

Impact of obstructive sleep apnea on postoperative outcomes after SADI-S: a retrospective MBSAQIP database analysis with literature review on behalf of TROGSS - The Robotic Global Surgical Society

Prognostic performance of the neutrophil-lymphocyte ratio for early complications following sleeve gastrectomy

MASLD or MAFLD: fatty liver by any name will pose the same challenge

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

The AI Revolution in Metabolic Surgery: A New Era Begins

Metabolic Syndrome, Obesity, and Hypertension: A Deep Dive

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Sarcopenia in the setting of nonalcoholic fatty liver

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

The AI Revolution in Metabolic Surgery: A New Era Begins

Metabolic Syndrome, Obesity, and Hypertension: A Deep Dive

M&TOD 2024 Best Paper Award Announced

Top 5 Most-Read Articles in Metabolism and Target Organ Damage for 2024

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico